aTyr Pharma | LIFE

Stock Price
0.79
Daily Change
-0.01 -1.33%
Monthly
-17.86%
Yearly
-75.82%
Q1 Forecast
0.78



Peers Price Chg Day Year Date
Ardelyx 5.70 0.06 0.98% 10.80% Mar/26
Biogen 191.03 1.85 0.98% 36.13% Mar/26
Bristol-Myers Squibb 59.40 0.46 0.78% 0.85% Mar/26
Clal Biotechnology 28.00 0.70 2.56% -17.16% Mar/25
Compugen 665.10 18.60 2.88% 19.15% Mar/25
Cipla 1,244.40 25.00 2.05% -15.70% Mar/25
Curis 0.61 -0.09 -12.44% -74.56% Mar/26
CSL 144.35 3.36 2.38% -42.81% Mar/26
Galapagos 26.42 -0.16 -0.60% 11.67% Mar/26
Grifols 7.61 -0.10 -1.30% 4.10% Mar/26


aTyr Pharma traded at $0.79 this Thursday March 26th, decreasing $0.01 or 1.33 percent since the previous trading session. Looking back, over the last four weeks, aTyr Pharma lost 17.86 percent. Over the last 12 months, its price fell by 75.82 percent. Looking ahead, we forecast aTyr Pharma to be priced at 0.78 by the end of this quarter and at 0.71 in one year, according to Trading Economics global macro models projections and analysts expectations.

aTyr Pharma Inc is a United States-based biotechnology company. The Company engaged in the development of medicines based on biology. The Company’s research and development efforts are concentrated on a new discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases.